Intervention With Omega Fatty Acids in High-risk Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Cardiovascular Disease
Interventions
DIETARY_SUPPLEMENT

Omega-3 Fatty Acid

Experimental: Omega-3 fatty acid In the intervention period the participants will receive a daily supplement of omega-3 fatty acids for 8 weeks, where the dosage are 3 and 4 g/day for women and men, respectively. The omega-3 supplement is a hydrolyzed and reesterified TAG fish oil, containing 33 area percent eicosapentaenoic acid and 22 area percent docosahexaenoic acid.

DIETARY_SUPPLEMENT

Omega-6 Fatty Acid

Experimental: Omega-6 fatty acid In the intervention period the participants will receive a daily supplement of omega-6 fatty acid for 8 weeks, where the dosage are 20 and 27 g/day for women and men, respectively. The omega-6 supplement is a high-quality organic, cold pressed and filtered safflower oil, containing 68-83% linoleic acid, 5-15% saturated fatty acid, 8-21% oleic acid, 0,0-0,5% ALA and maximum 2% other fatty acids.

All Listed Sponsors
collaborator

University of Bergen

OTHER

collaborator

University of Oslo

OTHER

lead

Haukeland University Hospital

OTHER

NCT02647333 - Intervention With Omega Fatty Acids in High-risk Patients | Biotech Hunter | Biotech Hunter